What CardioNow does

CardioNow is a privately held healthcare company that operates the Advanced Cardiac Center, a single preventative cardiology facility located at 19020 33rd Avenue West in Lynnwood, Washington, which held its grand opening on January 29, 2026. The center offers precision heart screening and specialist-level cardiology services aimed at early detection of cardiovascular disease before symptoms develop, including walk-in and scheduled appointments. Co-founded by Dr. Eugene Chang, the company positions itself as delivering specialist-level preventative cardiac care rather than acute interventional cardiology.

The service line is built around three advanced non-invasive diagnostic capabilities: Coronary CT Angiography for visualizing coronary arteries, Plaque Analysis for detecting and characterizing arterial plaque buildup, and FFR-CT (Fractional Flow Reserve computed tomography) for non-invasive assessment of blood-flow obstruction. Together these tools are intended to enable risk stratification and personalized care planning without surgical catheterization. CardioNow's revenue model is fee-for-service professional services, with visits billed via insurance or direct patient payment; pricing and payer mix are not publicly disclosed.

Customer acquisition is primarily direct-to-consumer through community awareness around the grand opening and PR-driven earned media, supplemented by referrals from primary-care physicians and cardiologists. The company's earlier identity, founded in 1999 and headquartered in Daly City, California, was as a healthcare information-technology vendor serving cardiologists with patient data and image management; that legacy funding history (~$11.57M raised across three rounds in 2001–2003, including a $6M round led by Fremont Ventures and Versant Ventures) is distinct from the current preventative-care operations and no longer reflects the business model. No institutional investors, ownership structure details, or financial metrics for the current phase are disclosed.

Name

CardioNow

Legal name

CardioNow

Website

https://cardionow.com

Company type

Private

Founded year

1999

Operating status

Operating

Short description

CardioNow operates the Advanced Cardiac Center, a single-site preventative cardiology clinic in Lynnwood, Washington, offering non-invasive precision heart screening — including Coronary CT Angiography, Plaque Analysis, and FFR-CT — to individual consumers seeking early detection of cardiovascular disease.

Ownership category

akta.pro rank

Product category

Preventative Cardiac Diagnostic Services

NAICS

Diagnostic Imaging Centers (621512), Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)

akta.pro secondary industries

Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK), Preventive Cardiology & Lipidology (HLAKABAF), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Preventative cardiac care
• Cardiac diagnostic imaging
• Non-invasive cardiology
• Heart disease screening
• Coronary CT angiography

Headquarters

HQ city

Daly City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Cardiac Screening Services: Fee-for-service revenue from precision heart screening and diagnostic imaging services offered at the Advanced Cardiac Center. Patients receive comprehensive cardiac assessments using advanced non-invasive diagnostic tools including Coronary CT Angiography, Plaque Analysis, and FFR-CT technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CardioNow operates a physical cardiac care facility (the Advanced Cardiac Center in Lynnwood, Washington) that delivers precision heart screening and specialist-level cardiology services to individual patients. The center uses advanced non-invasive diagnostic tools—Coronary CT Angiography, Plaque Analysis, and FFR-CT technology—to detect and characterize cardiovascular risk before symptoms develop, then produces personalized care plans based on each patient's diagnostic results.

Product overview

CardioNow operates the Advanced Cardiac Center, a single-facility cardiac care operation offering precision heart screening and specialist-level cardiology services. The center provides a suite of advanced noninvasive diagnostic tools including Coronary CT Angiography, Plaque Analysis, and FFR-CT technology, unified by a mission to empower patients with actionable insights and personalized care plans before symptoms develop.

Differentiator

Problem solved

Functional benefit

Products and services

• Advanced Cardiac Center A cardiac care facility providing precision heart screening and specialist-level cardiology services with advanced non-invasive diagnostic tools for early detection and prevention of heart disease, targeted at individuals seeking preventative cardiac assessments.
• Coronary CT Angiography Advanced non-invasive imaging service used to visualize coronary arteries and detect blockages or abnormalities for individual patients seeking early detection of heart disease, without requiring surgical intervention.
• Plaque Analysis Diagnostic analysis service that detects and characterizes arterial plaque buildup in order to assess cardiovascular risk and support early intervention and personalized care planning for individual patients.
• FFR-CT Technology Fractional Flow Reserve computed tomography service that enables non-invasive assessment of blood flow obstruction severity in coronary arteries, helping determine need for intervention in individual patients.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• Cleerly: Cleerly provides AI-enabled coronary CT angiography and plaque analysis software used by clinicians for cardiovascular risk assessment. It directly overlaps CardioNow's CCTA + Plaque Analysis stack and represents the leading software-defined competitor in the same clinical workflow.
• HeartFlow: HeartFlow is the developer of the original non-invasive FFR-CT technology for assessing coronary blood flow. It is the most direct technology comparable to CardioNow's FFR-CT service offering, though HeartFlow historically licenses its analysis to hospitals and imaging centers rather than operating consumer-facing clinics.
• LifeLine Screening: LifeLine Screening operates a national network of community-based preventive screening centers offering cardiovascular and other health screenings directly to consumers. It is the closest business-model comparable to CardioNow in delivering self-pay preventive screening through dedicated facilities.

Emerging players

• Prenuvo: Prenuvo operates consumer-facing whole-body MRI screening centers with a similar self-pay, preventive-health positioning. It is comparable on go-to-market (direct-to-consumer preventive imaging) rather than modality, and represents a benchmark for consumer marketing in preventive imaging.
• InsideTracker: InsideTracker offers consumer-facing blood-based preventive health and longevity testing with personalized action plans. It is comparable in its direct-to-consumer preventive positioning and personalized care-plan delivery, though it does not perform cardiac imaging.
• Function Health: Function Health is a consumer preventive-health platform offering comprehensive lab work and personalized health insights via membership. Comparable to CardioNow on the self-pay, preventive, insights-driven consumer model, though it relies on lab-based diagnostics rather than cardiac imaging.
• Ezra: Ezra offers full-body MRI-based preventive screening with a consumer subscription model. It is comparable to CardioNow in deploying advanced imaging as a consumer-paid preventive service, though Ezra focuses on oncology and whole-body imaging rather than cardiology.

Broad incumbents

• Cleveland HeartLab (Quest Diagnostics): Acquired by Quest Diagnostics, Cleveland HeartLab pioneered preventive cardiovascular biomarker testing offered through clinicians. It is comparable as a scaled preventive-cardiology franchise targeting the same 'screen before symptoms' thesis, though delivered via lab testing rather than imaging.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioNow